Concordance Of Breast Cancer Biomarker Testing In Core-Needle Biopsy And Surgical Specimens: A Single Institution Experience

Jessica Anne Slostad,Nicole Yun,Aimee Schad,Surbhi Warrior,Ruta Rao

CANCER RESEARCH（2021）

引用 3|浏览0

暂无评分

摘要

Overall, retesting ER and HER2 was more clinically beneficial than retesting PR. To aid decision-making and minimize healthcare costs, we propose patient-centered guidelines on retesting biomarker profiles.

查看译文

关键词

breast cancer,core needle biopsy,estrogen receptor,progesterone receptor,surgical pathology,tyrosine kinase-type cell surface receptor (human epidermal growth factor receptor 2 HER2)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要